BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31075282)

  • 1. Rationally designed small molecules targeting toxic CAG repeat RNA that causes Huntington's disease (HD) and spinocerebellar ataxia (SCAs).
    Khan E; Biswas S; Mishra SK; Mishra R; Samanta S; Mishra A; Tawani A; Kumar A
    Biochimie; 2019 Aug; 163():21-32. PubMed ID: 31075282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Insights Reveal the Dynamics of the Repeating r(CAG) Transcript Found in Huntington's Disease (HD) and Spinocerebellar Ataxias (SCAs).
    Tawani A; Kumar A
    PLoS One; 2015; 10(7):e0131788. PubMed ID: 26148061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs).
    Khan E; Tawani A; Mishra SK; Verma AK; Upadhyay A; Kumar M; Sandhir R; Mishra A; Kumar A
    ACS Chem Biol; 2018 Jan; 13(1):180-188. PubMed ID: 29172480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a potent small molecule inhibiting Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein.
    Khan E; Mishra SK; Mishra R; Mishra A; Kumar A
    Sci Rep; 2019 Nov; 9(1):16872. PubMed ID: 31728006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder.
    Matthes F; Massari S; Bochicchio A; Schorpp K; Schilling J; Weber S; Offermann N; Desantis J; Wanker E; Carloni P; Hadian K; Tabarrini O; Rossetti G; Krauss S
    ACS Chem Neurosci; 2018 Jun; 9(6):1399-1408. PubMed ID: 29506378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA toxicity induced by expanded CAG repeats in Huntington's disease.
    Martí E
    Brain Pathol; 2016 Nov; 26(6):779-786. PubMed ID: 27529325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of CAG repeat instability in the central nervous system and periphery in Huntington's disease and in spinocerebellar ataxia type 1.
    Mouro Pinto R; Arning L; Giordano JV; Razghandi P; Andrew MA; Gillis T; Correia K; Mysore JS; Grote Urtubey DM; Parwez CR; von Hein SM; Clark HB; Nguyen HP; Förster E; Beller A; Jayadaev S; Keene CD; Bird TD; Lucente D; Vonsattel JP; Orr H; Saft C; Petrasch-Parwez E; Wheeler VC
    Hum Mol Genet; 2020 Aug; 29(15):2551-2567. PubMed ID: 32761094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat-associated non-AUG translation induces cytoplasmic aggregation of CAG repeat-containing RNAs.
    Das MR; Chang Y; Anderson R; Saunders RA; Zhang N; Tomberlin CP; Vale RD; Jain A
    Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2215071120. PubMed ID: 36623192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.
    Rué L; Bañez-Coronel M; Creus-Muncunill J; Giralt A; Alcalá-Vida R; Mentxaka G; Kagerbauer B; Zomeño-Abellán MT; Aranda Z; Venturi V; Pérez-Navarro E; Estivill X; Martí E
    J Clin Invest; 2016 Nov; 126(11):4319-4330. PubMed ID: 27721240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference.
    Murmann AE; Patel M; Jeong SY; Bartom ET; Jennifer Morton A; Peter ME
    Cell Death Dis; 2022 Dec; 13(12):1078. PubMed ID: 36585400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.
    de Mezer M; Wojciechowska M; Napierala M; Sobczak K; Krzyzosiak WJ
    Nucleic Acids Res; 2011 May; 39(9):3852-63. PubMed ID: 21247881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat associated non-ATG translation initiation: one DNA, two transcripts, seven reading frames, potentially nine toxic entities!
    Pearson CE
    PLoS Genet; 2011 Mar; 7(3):e1002018. PubMed ID: 21423665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAG repeat RNA as an auxiliary toxic agent in polyglutamine disorders.
    Wojciechowska M; Krzyzosiak WJ
    RNA Biol; 2011; 8(4):565-71. PubMed ID: 21593608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of RAN-mediated toxicity in Huntington's disease knock-in mice.
    Yang S; Yang H; Huang L; Chen L; Qin Z; Li S; Li XJ
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4411-4417. PubMed ID: 32029588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA NEAT1 is elevated in polyglutamine repeat expansion diseases and protects from disease gene-dependent toxicities.
    Cheng C; Spengler RM; Keiser MS; Monteys AM; Rieders JM; Ramachandran S; Davidson BL
    Hum Mol Genet; 2018 Dec; 27(24):4303-4314. PubMed ID: 30239724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.
    Zeng Y; Guo W; Xu G; Wang Q; Feng L; Long S; Liang F; Huang Y; Lu X; Li S; Zhou J; Burgunder JM; Pang J; Pei Z
    Drug Des Devel Ther; 2016; 10():1443-51. PubMed ID: 27110099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation.
    Bech S; Petersen T; Nørremølle A; Gjedde A; Ehlers L; Eiberg H; Hjermind LE; Hasholt L; Lundorf E; Nielsen JE
    Parkinsonism Relat Disord; 2010 Jan; 16(1):12-5. PubMed ID: 19595623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the Pathogenic CAG Expansion Length in Huntington's Disease?
    Donaldson J; Powell S; Rickards N; Holmans P; Jones L
    J Huntingtons Dis; 2021; 10(1):175-202. PubMed ID: 33579866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
    Podvin S; Reardon HT; Yin K; Mosier C; Hook V
    J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.